Journal of Applied Physiology · 2015 · 19 citations · 58 references
MedicinePharmacologyPharmacotherapyExercise PhysiologyExercise PrescriptionExercise TestingBreathing ExercisesCardiopulmonary Exercise TestingDyspnea ManagementOpioid PharmacologyDyspnea ReductionExercise DyspneaExercise EnduranceExercise Ventilatory ResponseOpioids For DyspneaPharmacologic Dyspnea TherapyRespiratory Muscle PerformanceRestrictive Ventilatory Pattern
Few therapies exist for the relief of dyspnea in restrictive lung disorders. Accumulating evidence suggests that nebulized opioids selective for the mu-receptor subtype may relieve dyspnea by modulating intrapulmonary opioid receptor activity. Our respective primary and secondary objectives were to test the hypothesis that nebulized fentanyl (a mu-opioid receptor agonist) relieves dyspnea during exercise in the presence of abnormal restrictive ventilatory constraints and to identify the physiological mechanisms of this improvement. In a randomized, double-blind, placebo-controlled crossover study, we examined the effect of 250 μg nebulized fentanyl, chest wall strapping (CWS), and their interaction on detailed physiological and perceptual responses to constant work rate cycle exercise (85% of maximum incremental work rate) in 14 healthy, fit young men. By design, CWS decreased vital capacity by ∼20% and mimicked the negative consequences of a mild restrictive lung disorder on exercise endurance time and on dyspnea, breathing pattern, dynamic operating lung volumes, and diaphragmatic electromyographic and respiratory muscle function during exercise. Compared with placebo under both unrestricted control and CWS conditions, nebulized fentanyl had no effect on exercise endurance time, integrated physiological response to exercise, sensory intensity, unpleasantness ratings of exertional dyspnea. Our results do not support a role for intrapulmonary opioids in the neuromodulation of exertional dyspnea in health nor do they provide a physiological rationale for the use of nebulized fentanyl in the management of dyspnea due to mild restrictive lung disorders, specifically those arising from abnormalities of the chest wall and not affiliated with airway inflammation.
58
Psychophysical bases of perceived exertion
Gunnar Borg · Medicine & Science in Sports & Exercise · 1982 · 16.4K citations
Martin R. Miller, J. Hankinson, Vito Brusasco et al. · European Respiratory Journal · 2005 · 15.7K citations · Full text
The validation of visual analogue scales as ratio scale measures for chronic and experimental pain
Donald D. Price, Patricia McGrath, Amir Rafii et al. · Pain · 1983 · 3.9K citations
Nursing, Psychology, Pain Medicine +16
Mark B. Parshall, Richard M. Schwartzstein, Lewis Adams et al. · American Journal of Respiratory and Critical Care Medicine · 2012 · 1.8K citations · Full text
The Number of Alveoli in the Human Lung
Matthias Ochs, Jens Randel Nyengaard, Anja Jung et al. · American Journal of Respiratory and Critical Care Medicine · 2003 · 761 citations
Medicine, Anatomy, Physiology +15